Considering the downregulation of APOH might be an initial factor to break the balance of enterohepatic circulation, it is valuable to exploit a favorable treatment target for maintaining the metabolic balance of the body and bring a new therapeutic strategy for fatty liver disease. Here, APOH is linked to fatty liver disease.